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Abstract
ONZIN is abundantly expressed in immune cells of both the myeloid and lymphoid lineage. 
Expression by lymphoid cells has been reported to further increase after cutaneous exposure of 
mice to antigens and haptens capable of inducing contact hypersensitivity, suggesting that ONZIN 
plays a critical role in this response. Here, we report that indeed ONZIN-deficient mice develop 
attenuated CHS to a number of different haptens. Dampened CHS responses correlated with a 
significant reduction in pro-inflammatory IL-6 at the challenge site in ONZIN-deficient animals 
compared to wild type controls. Together the study of these animals indicates that loss of ONZIN 
impacts the effector phase of the CHS response through the regulation of pro-inflammatory 
factors.
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INTRODUCTION
ONZIN is a small cysteine-rich cytoplasmic protein expressed at high levels in both cells of 
the immune system and in many epithelia, particularly that of the intestinal and respiratory 
tracts1. Promoter analysis suggests that the expression of this gene is subject to regulation 
during immune responses (unpublished data) and genome wide expression studies have 
identified increased levels of ONZIN in inflammatory lesions. Despite these findings, 
relatively little progress has been made in assigning a role for ONZIN in specific immune 
responses. Recent studies have shown that ONZIN has an important function in the innate 
immune response to bacterial infections. Studies from our lab have demonstrated that 
expression of ONZIN by neutrophils is necessary for optimal intracellular killing of several 
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common pathogens1. However, an independent function in adaptive immune responses is 
suggested by expression of ONZIN in cells orchestrating this response: T cells and dendritic 
cells (DCs). Subtractive hybridization using cDNA obtained from monocyte-derived DCs 
versus plasmacytoid-derived DCs identified Onzin as a gene that is differentially expressed 
between these two populations of human DCs2. Whereas ONZIN expression was relatively 
high in plasmacytoid dendritic cells, only minimal levels of expression were observed in 
monocyte-derived DCs2. This differential expression is of particular interest as plasmacytoid 
dendritic cells have been observed to differentiate into mature dendritic cells capable of 
priming CD4+ T cells toward either Th1 or Th2 responses depending on the activation 
stimuli. In an independent cDNA microarray analysis, Onzin was identified as a gene highly 
up-regulated in draining auricular lymph node tissue following a primary exposure to the 
contact allergen DNFB3. Onzin was maximally expressed 48 hours after exposure and 
represented one of the most up-regulated genes observed in the lymph tissue by 
transcriptional profiling. While this experimental data suggested the importance of ONZIN 
in this DC/T cell interaction, a defined role for ONZIN in this process has not established.
Contact hypersensitivity (CHS), is a type of DTH reaction, caused by repeated epicutaneous 
exposure to a known contact allergen (reviewed in4). CHS can be induced experimentally in 
mice by topical application of sensitizing agents, such as Oxazalone or DNFB. The resulting 
response mimics the reactions observed in groups of people sensitive to poison ivy, various 
drugs and industrial or household chemicals. CHS develops through several distinct steps, 
which remain the focus of much research. The first phase, sensitization, occurs after an 
initial epicutaneous allergen exposure and typically little to no symptoms of exposure are 
evident at this point. In the elicitation phase, allergen specific memory T cells residing 
within the lymphatics are activated upon re-exposure by the same allergen. An immune 
response is provoked at the site of the second encounter resulting in a local inflammatory 
reaction characterized clinically as allergic contact dermatitis5.
Animal models of CHS often use haptens, which are non-proteinaceous substances that 
themselves do not elicit antibody formation but act through altering endogenous proteins 
that results in their immunogenicity. During the different phases of CHS, several cell types 
have been identified as key players during a hypersensitivity reaction. First, Langerhans 
cells (LC), a type of dendritic cell that resides in the epidermis, grasp the hapten at the 
primary site of contact and migrate to draining lymph nodes (LNs). Once there, the resident 
naïve T cells are primed against the hapten through a T cell-LC interaction. Re-exposure of 
the same hapten at a distant secondary site, leads to an inflammatory response with a cellular 
infiltrate containing a wide variety of immune cells: macrophages, neutrophils and T cells.
In this study, we utilized Onzin−/− mice in order to elucidate the role(s) of ONZIN in these 
cellular mediated inflammatory diseases and immune responses. Using this model we 
demonstrate that not only does ONZIN expression increase during this response but also its 
expression is necessary for normal contact hypersensitivity responses in mice.
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ONZIN expression in draining auricular lymph nodes
Previous studies indicate that ONZIN expression in draining auricular nodes is increased 
after a single exposure to the hapten DNFB3. To determine whether this increase was limited 
to the sensitization phase of the response and/or the response to this specific hapten, 
C57BL/6 Onzin−/− and wild type mice were sensitized to oxazolone and challenged 5 days 
later. The draining auricular LNs associated with either the oxazalone treated ear or the 
untreated ear were collected 24 and 48 hours after challenge. Protein lysates were prepared 
and analyzed by SDS-PAGE and western using an ONZIN specific antibody. As shown in 
figure 1A, ONZIN expression was dramatically increased in lysates prepared from the 
draining auricular LN associated with the oxazalone treated ears at both time points. Lysates 
prepared from the LNs associated with both naïve and the vehicle treated ear had 
comparable levels of ONZIN expression as demonstrated by western analysis (figure 1A). 
Densitometry analysis of westerns containing multiple LN lysates from each sample type 
was used to quantify relative levels of ONZIN expression (figure 1B).
Delayed type hypersensitivity in ONZIN deficient mice
We next examined a possible role for ONZIN in the CHS reaction induced by oxazalone. 
Wild type and C57BL/6 Onzin−/− animals were sensitized to oxazalone by a topical 
application to the shaved abdomen. The mice were challenged after five days by application 
of the sensitizing agent to the left pinna, while the right was treated with vehicle. The 
response to oxazalone was assessed using a number of criteria including the difference in the 
weight of the tissue biopsies obtained from the vehicle and hapten treated ears. As expect a 
treatment of sensitized WT C57BL/6 mice with oxazalone resulted in a robust increase the 
weight of the tissue biopsies 12 hours after challenge (figure 2A). This increase in weight 
was more pronounced 24 hours after treatment with impending resolution of the response 
evident 48 hours after exposure. As shown in figure 2A, the response of the ONZIN 
deficient mice was attenuated at all time points examined, and this difference achieved 
statistical significance at both 24 and 48 hours after challenge.
Change in the weight of tissue after induction of the immune response reflects increases in 
cellularity, increased blood flow to the tissue and edema formation. We therefore 
determined which of these parameters were attenuated in the ONZIN deficient animals. CHS 
was induced as described above and animals and tissues collected 24 hours after challenge. 
This tissue was fixed, stained, and the number of immune cells present determined by 
microscopy. As expected, low numbers of resident immune cells could be identified in the 
sections obtained from the vehicle treated pinna (figure 2B). In contrast, leukocytes were 
abundant in the wild type tissue treated with oxazalone. While leukocytes could also be 
easily detected in the sections from the Onzin−/− mice, the number of these cells was 
significantly lower (figure 2C).
Neutrophils, easily identified based on morphological criteria, comprised a high percentage 
of cells present in the inflamed wild type tissue. Few neutrophils appeared to be present in 
tissue from similarly treated Onzin−/− mice. To verify this, mice were again sensitized and 
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challenges with the hapten, oxazalone. Tissues biopsies were obtained and the amount of 
myloperoxidase (MPO), an enzyme specific to neutrophils, present in the sample 
determined. Consistent with the histological observation, the amount of MPO was reduced 
to about 50% of that observed in the wild type animals (figure 2D). We next determined 
whether the attenuated cellularity observed in the tissue of the Onzin−/− mice was paralleled 
by a decrease in edema formation in response to challenge with hapten. Mice were treated 
with Evans Blue, a dye that binds to serum proteins. Because of this binding, extravasation 
of serum proteins into the tissue is paralleled by increased levels of Evans Blue measured in 
tissue and is therefore indicative of vascular permeability due to the induced inflammation. 
Treatment of wild type mice with hapten resulted in a measurable increases in serum protein 
present in the tissue biopsies: this was reduced by about 50% in the Onzin−/− mice (figure 
2E).
To determine if the decreased vascular permeability to oxazalone challenge is indicative of a 
generalized defect in the ability of the Onzin−/− mice to respond to cutaneous inflammatory 
insults by altering vascular permeability and recruit circulating leukocytes, we examined 
these mice in an arachidonic acid (AA) induced acute model of cutaneous inflammation. 
WT and Onzin−/− mice received 0.5% Evans blue dye i.v. immediately prior to application 
of AA to the left ear. The acute response to AA was first analyzed by collecting and 
weighing 8 mm ear discs. Intense ear swelling was observed within 1 hour of challenge with 
ear weight changes of greater than 10 mg (figure 2F). However, there was no significant 
difference in ear weight change between the wild type and Onzin−/− animals (figure 2F). 
Extravasation of plasma proteins into tissue was also quantified by extraction of Evan’s blue 
dye followed by analysis of the extracts. Vascular permeability due to AA challenge did not 
differ between the Onzin−/− and control animals (figure 2G).
DNFB induced CHS in ONZIN Deficient mice
A number of haptens, in addition to oxazalone, have been described that are capable of 
eliciting contact hypersensitivity. As small differences in the pathophysiology of the 
immune response to different haptens have been noted, we next determined whether the 
attenuated response of the Onzin−/− mice was generally observed in CHS by treating 
Onzin−/− and wild type animals with DNFB. In general the response of the mice to DNFB 
was less robust than the responses elicited by oxazalone. However, again we observed a 
decreased CHS DNFB-induced reaction in the animals lacking ONZIN (figure 3).
Oxazalone sensitization and challenge post bone marrow transplant
To further define the mechanism by which ONZIN contributes to CHS response, we asked 
whether expression of ONZIN, by hematopoetic cells specifically was required for optimal 
response to oxazalone. ONZIN is expressed by some epithelial cell populations, including 
those of the digestive and respiratory tracts and at low levels in the skin1. To address which 
cell population ONZIN is interacting with in this response, bone marrow chimeras were 
generated in which the loss of ONZIN expression was limited either to somatic cells or to 
cells of hematopoietic origin. In addition, two control populations were generated, the first 
consisting of wild type mice reconstituted with wild type marrow, and the second consisting 
of Onzin−/− mice reconstituted with Onzin−/− marrow. All mice were exposed to a lethal 
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dose of irradiation prior to receiving the donor marrow and allowed to recover for four 
weeks prior to sensitization with the hapten. A robust response was observed in the wild 
type population of mice reconstituted with wild type marrow indicating this experimental 
protocol did not interfere with the ability of the mice to mount a CHS response (figure 4A, 
WT:WT). However, as expected the response was attenuated in the Onzin−/− mice 
reconstituted with Onzin−/− bone marrow (figure 4A, KO:KO).
If ONZIN deficient hematopoetic cells are the primary mediators of the diminished 
hypersensitivity response, then the mice lacking ONZIN but reconstituted with wild type 
bone marrow should display a response to oxazalone similar to that of wild type animals. 
Indeed, oxazalone-provoked tissue inflammation in these animals was not significantly 
different from that observed in the wild type mice that received wild type bone marrow 
(figure 4A, WT:KO). Conversely, wild type irradiated mice reconstituted with Onzin−/− 
BM demonstrated a significantly attenuated response to oxazalone (p<0.01 compared to 
wild-type mice with wild-type marrow) (figure 4A, KO:WT).
Neutrophil depletion does not affect contact hypersensitivity to oxazalone
Onzin is expressed at high levels in neutrophils and previous studies have indicated that, at 
least under some experimental conditions, these cells contribute to the tissue inflammation 
characteristic of CHS6. To determine whether loss of ONZIN might attenuate CHS through 
a function in this cell type we first determined whether we could measure a contribution of 
neutrophils to this response under our experimental conditions. Towards this end, 
oxazaolone sensitized mice were depleted of mature neutrophils by treatment with anti Gr-1 
antiserum prior to challenge with oxazalone. To our surprise, no significant difference was 
observed in the DTH response to either oxazalone or DNFB in these neutrophil-depleted 
animals compared to control animals (figure 4B). The successful elimination of the 
neutrophil population was verified by measurement of MPO levels in the ear tissue after 
treatment with oxazalone (figure 4C) and by induction of peritonitis in a parallel group of 
animals (data not shown). Thus in this model, neutrophils do not contribute significantly to 
the effector phase of the response, making it unlikely that loss of ONZIN expression in 
neutrophils contributes to the diminished CHS observed in the Onzin−/− animals.
Antigen acquisition, migration and presentation in Onzin−/− mice
After epicutaneous exposure to allergen, epidermal Langerhans cells (LCs) are induced to 
migrate from the skin and accumulate as dendritic cells (DCs) in the draining lymph node 
where they interact with allergen-specific T cells7. We next sought to determine if the 
attenuated hypersensitivity responses observed in ONZIN deficient mice is due to a defect in 
the sensitization phase, such as a failure in antigen acquisition or migration by dendritic 
cells. FITC, unlike most haptens, is fluorescent. This feature aids in identification and 
trafficking studies of cells that have taken up the antigen7. After epicutaneous sensitization 
with the fluorescent antigen, FITC, cells from draining LNs were isolated and analyzed by 
flow cytometry. Equivalent percentages of FITC+ CD11c+ double positive dendritic cells 
were collected from the draining lymph nodes of wild type and Onzin−/− mice (figure 4D). 
Additionally, there were no differences in the percentage of FITC+ cells from the CD11c+ 
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gated subset (figure 4E) indicating that equivalent proportions of DCs were migrating to the 
inguinal LNs from the skin after topical application of FITC.
To further examine the impact of loss of ONZIN expression on antigen presentation and 
resultant T cell responses, we examined the capacity of ONZIN deficient cells to respond to 
stimulation in a mixed-lymphocyte reaction (MLR). Splenocyte suspensions were prepared 
from age matched WT and Onzin−/− C57BL/6 mice and proliferation was stimulated upon 
co-culture with WT BALB/c irradiated cells. Cultured splenocytes from both ONZIN 
deficient and control mice demonstrated equivalent levels of proliferation to the allogenic 
stimulator cells as shown by H3 incorporation (figure 4F). An additional MLR experiment 
was conducted to determine if differences in the proliferative response would be observed 
by utilizing Onzin−/− BALB/c irradiated cells as stimulators. The responder cell population 
was isolated from WT and Onzin−/− C57BL/6 splenocytes. Both WT and Onzin−/− cells 
were induced to proliferate by the Onzin−/− allogenic stimulator cells (figure 4G).
Adoptive transfer of sensitized lymph node cells
The diminished response of the Onzin−/− mice could reflect a defect in sensitization to 
antigen or failure to respond to antigen upon challenge. To distinguish between these two 
possibilities wild type and Onzin−/− mice were only sensitized with oxazalone and the 
draining axillary and inguinal LNs were collected. A single cell suspension isolated from the 
sensitized mice was then injected into naïve WT and Onzin−/− recipients. A sample of each 
population was analyzed by flow cytometry to verify that there was no difference in the 
cellular composition, including PMNs, antigen presenting cells, T and B cells of lymph 
nodes of the Onzin−/− and wild type mice (figure 5A,B). If the decreased DTH response 
observed in the ONZIN deficient mice is due to impairment in sensitization to antigen, 
including the migration of Langerhan cells, then the transfer of T cells isolated from the 
sensitized lymph nodes of the wild type animals should normalize the response. As expected 
C57BL/6 WT mice that received sensitized leukocytes from WT mice showed a robust 
immune response upon their first exposure to the hapten (figure 5C, WT:WT). A similar 
response was observed when wild type mice received cells from sensitized Onzin−/− mice 
(KO:WT). In contrast, the response of naïve Onzin−/− mice that received wild type 
sensitized cells remained significantly attenuated after challenge with oxazalone suggesting 
a defect in the effector/elicitation phase of the response (figure 5C).
To further characterize the effector/elicitation phase of the DTH response induced by 
oxazolone in WT and Onzin−/− mice, we analyzed the cellular composition of the auricular 
draining lymph nodes. Cells were isolated 24 hrs post challenge from draining nodes and 
stained with antibodies specific for various leukocyte populations. FACs analysis revealed 
no significant difference in the relative number of CD4+ or CD8+ T cells, B cells, 
macrophages, neutrophils or dendritic cells between the WT and Onzin−/− mice (figure 5D). 
Dendritic cells from draining lymph node expressed comparable level of GR-1, Mac-1 and 
MHC II suggesting similar maturity and/or activation of this population in WT and Onzin−/− 
mice8 (figure 5E).
To further define differences and similarities in the response of Onzin−/− and wild type mice 
during the challenge phase of the DTH response we profiled the expression of cytokines at 
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the site of antigen exposure. Sensitized mice were challenged with oxazolone and six hours 
later tissue was collected from the control and the antigen treated ears. RNA or protein was 
prepared and the expression of CXCL1, IL-6, IL-2, IL-4, IL-17e, IL-12, CCR7 and CCR6 in 
the control and challenged tissue evaluated by real time PCR (RNA) or ELISA (protein). 
This analysis revealed a significant difference between the Onzin−/− and wild type animals 
in the expression of IL-6 and CXCL1 (figure 6A,B). As expected the mRNA levels for both 
IL-6 and CXCL1 were increased in biopsies from the antigen exposed tissue compared to 
control tissue. However, this increase was significantly blunted in the Onzin−/− mice. To 
verify these findings we determined whether a corresponding difference in the level of IL-6 
and CXCL1 could be detected in protein extracts prepared from the tissue after challenge. 
Consistent with our RNA analysis the levels of both CXCL1 and IL-6 were elevated in the 
antigen challenges tissue of WT mice. Again the elevation in IL-6 observed in tissue from 
wild type animals was significantly blunted in the Onzin−/− mice, similar to that of vehicle 
controls (figure 6C). Similarly, the accumulation of CXCL1 in the challenge site was 
attenuated in the ONZIN deficient mice, however, in this case the difference between the 
level of this chemokine in the wild type and Onzin−/− mice did not achieve statistical 
significance (figure 6D). There were no significant differences in IL-2, IL-4, IL-17e, CCR6, 
CCR7 and IL-12 at the timepoints tested (figure 6E–J).
DISCUSSION
ONZIN was first identified in a screen of LIF regulated genes in the mouse uterus over 10 
years ago9. Despite this, remarkably little is known regarding the function of this relatively 
abundant protein. Early reports, however, showed that ONZIN was highly induced in lymph 
nodes draining regions of the skin exposed to contact allergens3. This raised the possibility 
that ONZIN might be essential for mounting a response to these chemicals. Certainly this 
possibility needed to be considered given the demonstration that ONZIN is expression in 
virtually all the immune populations that play a critical role in orchestrating the response to 
contact allergens1.
We found that, consistent with the elevated expression of ONZIIN in draining nodes after 
contact with chemical allergen, mice lacking ONZIN showed an impaired response to two 
commonly studied chemical allergens, oxalozone and DNFB. Loss of ONZIN affected a 
number of different parameters used to evaluate the pathogenesis of the response to these 
agents, including recruitment of immune cells and edema formation upon secondary contact 
with the chemical. The attenuation of the response to these chemical allergens did not reflect 
a universal deficit in the ability of the mice to respond to topical immune challenges, as the 
immune response to heightened production of leukotrienes in the skin resulted in expected 
increases in vascular permeability, extravasation of serum proteins and recruitment of 
neutrophils in ONZIN deficient mice.
Extensive knowledge concerning the expression of ONZIN has been amassed from various 
studies1–3. ONZIN is not ubiquitously expressed and while it is found at high levels in most 
immune cells, with high levels observed in cells of myeloid lineage and lymphocytes, its 
expression is not limited to hematopoetic cells. High levels can also be observed in epithelial 
cells, particularly in the lung and intestinal tract and ONZIN expression can be detected in 
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the skin1. However, our experiments show that it is the expression of ONZIN by bone 
marrow derived cells that appears to be critical in DTH as mice reconstituted with ONZIN 
deficient bone marrow showed an impaired response to oxazolone compared to those 
reconstituted with WT marrow.
Although the expression of ONZIN in the various dendritic cell populations of the skin is 
not know, ONZIN expression by plasmacytoid dendritic cells has been documented2. This 
suggests the possibility that loss of ONZIN could impact the sensitization phase of the DTH 
response by altering the functioning of dendritic cells, either their ability to capture antigen 
or their ability to migrate to draining nodes for antigen presentation. Multiple populations of 
epidermal and dermal dendritic cells have been identified in the mouse. One of these, the 
epidermal dendritic cell population is radiation resistant and therefore is expected to be of 
host origin in the bone marrow chimeras10,11. This makes it unlikely that a deficit in these 
cells results in the impaired DTH, as the response is normalized when Onzin−/− mice are 
reconstituted with wild type bone marrow. However, some studies suggest that this 
population of cells may primarily play a regulatory role in the DTH response and that other 
dendritic cell populations derived from circulating precursors, present in both the dermis and 
epidermis, play a critical role in antigen capture and presentation to T cells12. This function 
of dendritic cells can be evaluated by using the florescent chemical antigen FITC. The 
uptake of this fluorescent antigen facilitates the detection of cells that have trafficked from 
the skin to the draining nodes after exposure. Based on these criteria, we could detect no 
deficit in antigen capture and subsequent trafficking of dendritic cells to the lymph nodes in 
the Onzin−/− animals.
To further assess a possible impact of loss of ONZIN on antigen presentation and 
subsequent T cell proliferation, we evaluated the ability of ONZIN deficient cells to either 
stimulate or respond in a mixed lymphocyte reaction. To do this the ONZIN null allele was 
move to the H2D genetic background by several consecutive crosses to BALB/c mice. This 
provided cells differing at the MHC from the cogenic C57BL/6 line. However, no difference 
was observed in the ability of ONZIN deficient splenocytes to stimulate proliferation of 
allogenic T cells, again indicating that loss of this protein did not interfere with presentation 
of antigen to naïve T cells. The expansion of T cells in response to allogenic stimuli was 
also not altered by the loss of ONZIN. While clearly this does not rule out possible defects 
in the T cells response to presentation of chemical allergens in vivo, it does suggest that the 
fundamental ability of antigen presenting cells to elicit T cells responses is not disturbed by 
loss of ONZIN.
Perhaps the strongest evidence demonstrating that the attenuated DTH response of the 
Onzin−/− mice does not reflect a defect in sensitization comes from our demonstration that 
cells collected from LN of oxalozone sensitized ONZIN deficient mice can transfer 
sensitivity to this antigen to naïve wild type animals. The immune response elicited on 
contact to oxazlone did not differ in these animals from the response observed in naïve 
animals reconstituted with cells collected from the LN of similarly treated wild type 
animals.
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The ability of LN cells from KO mice to transfer sensitivity to naïve animals, together with 
the studies of the DTH response in the bone marrow chimeras, indicates that the defect in 
the hematopoietic cell function does not reflect a deficit in the function of the hematopoietic 
cells during sensitization, but rather their functioning as effector cells during challenge. 
Upon re-exposure to antigen CD4+ T cells interact with local antigen presenting cells and 
induce local inflammation characterized by production of chemokines and cytokines and 
thus leading to recruitment of additional populations of leukocytes, including neutrophils. 
The ability of Onzin−/−lymph node cells to transfer sensitivity to naïve animals, makes it 
unlikely that the attenuated response in the ONZIN null animals reflect a deficit in the 
recruitment of T cells to the skin after re-exposure to the antigen. Rather, it suggests that 
loss of ONZIN leads to a deficit in the functioning of an additional population(s) of effector 
leukocytes which response to signals initiated by the recruited T cells. An attractive 
candidate population is the neutrophil, cells which express high levels of ONZIN1 and have 
been reported to drive the effector phase of the DTH response13,14. Additionally, in 
Onzin−/− mice we found decreased levels of CXCL1, a major neutrophil recruiting 
chemokine, in the challenge site as compared to WT mice, which further supported of a 
possible neutrophil-mediated contribution to the attenuated DTH response in Onzin−/− mice.
Neutrophils have been reported to contribute to the DTH response, and consistent with this 
we observe neutrophils in the inflamed skin of sensitized mice after antigen challenge. 
Neutrophil influx in the site of antigen challenge was easily quantified by measuring levels 
of the neutrophil specific enzyme myeloperoxidase in tissue homogenates. Previous studies 
have reported that neutrophils contribute to the effector phase of the DTH13. In these studies 
DTH is carried out in animal in which neutrophils population have been depleted by 
treatment with anti-Ly-6G antibody. Given this, it was reasonable to assume that if 
neutrophils contribute to the DTH response and expression of ONZIN is essential for the 
normal function of the neutrophils during the challenge phase of DTH, the impaired 
response of Onzin−/− animals compared to wild type animals will not be apparent in 
neutrophil depleted mice. However, despite the observance of neutrophils in the tissue 
challenged with oxazalone we were unable to demonstrate a contribution of these cells to a 
measurable change in the inflammatory response upon re-exposure to antigen. No difference 
was observed in the extent of tissue swelling and increase in tissue weight in the antibody 
treated (neutrophil depleted) animals compared to control. Our inability to detect a 
measurable contribution of neutrophils to oxazalone induced DTH makes it unlikely that 
ONZIN expression in these cells contributes to the response.
Similar to neutrophils, macrophages express high levels of ONZIN as well1. These cells 
accumulate in the skin after re-exposure to antigen and once activated produce a number of 
chemokines, many of which have been shown to contribute the magnitude of the DTH 
response: MIP-1α, IL-6, IL-10, IL-12, MCP-1 and CXCL115. We found no differences in 
the levels of the majority of these cytokines/chemokines, including IL-2, IL-4, IL-17e, 
IL-12, CCR7 and CCR6 in the tissue after antigen challenge. A notable exception however 
was IL-6. RNA expression at 6 hrs and protein expression by 16 hrs were significantly 
elevated in WT challenged mice. In contrast, IL-6 RNA and protein levels remained low at 
both of these timepoints, at similar levels to the vehicle treated ears. Interestingly, studies in 
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IL-6−/− mice show that induction of contact hypersensitivity is significantly reduced when 
IL-6 is absent and that IL-6 appears to be more important for the later phases of contact 
hypersensitivity induced by oxazalone16. These findings are in agreement with our study 
showing that the role of ONZIN during a DTH response is during the elicitation phase and 
not during the sensitization phase. Since IL-6 levels are attenuated in challenged Onzin−/− 
mice and since IL-6 is known to act as a proinflammatory cytokine that recruits other cells 
and is also involved in vascular cell adhesion molecule regulation17, further studies 
examining the role of ONZIN is regulating IL-6 production from various cell types should 
be explored.
Additionally, ONZIN has been shown to bind phospholipid scramblase-1 (PLSCR1)18, an 
endofacial membrane protein that has been suggested to mediate the bidirectional movement 
of plasma membrane phospholipids in response to high levels of cytosolic calcium, injury, 
or apoptotic insult19–21. There is also evidence that PLSCR1 interacts with a number of 
molecules involved in cytokine signaling. Decreased cytokines or chemokines secreted from 
immune cells, such as IL-6, through ONZIN’s interaction and binding with PLSCR1 may be 
a mechanism by which ONZIN is involved in regulating the elicitation phase during CHS 
reactions and should be explored in more detail in future experiments.
In summary, findings presented here show that loss of ONZIN impairs the ability of mice to 
mount a DTH response. This does not reflect a deficit in the ability of the Onzin−/− mice to 
become sensitized to chemical antigens, rather, the defect appears to reflect impaired 
effector cell function after re-exposure to antigen. Contact hypersensitivity is one of the 
most intensively investigated immune responses in vivo and is regarded as a prototype of T 
cell-mediated delayed-type hypersensitivity reactions. Virtually all of the mouse lines 
generated over the past twenty years that carry mutations in immune related genes have been 
evaluated in models of CHS and DTH. In the majority of cases, the change in the response 
of the mutant lines is associated with impaired sensitization to allergen. Few studies have 
identified genes critical only to the immune response elicited on re-exposure to antigen. 
Identification of molecules such as ONZIN that contribute to this aspect of DTH is 
important, as these molecules likely provide more desirable targets for therapeutic 
intervention in the many diseases modeled by CHS and DTH.
METHODS
Experimental mice
Mice deficient in Onzin were generated as previously described1. 129/SvEv Onzin+/− mice 
were backrossed to both C57BL/6 and BALB/c backgrounds for 12 generations. Onzin+/− 
mice from the twelfth generation backross were intercrossed and the resultant mouse 
colonies formed from Onzin+/+ and Onzin−/− progeny. F1 129/B6−/− mice were generated 
by the intercross of 129/SvEv−/− mice and C57BL/6−/− mice, which were derived from 
intercross of N12 C57BL/6+/−. Wild type congenic F1 mice were generated by intercross of 
the corresponding wild type littermates. All studies were conducted in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals as well as 
the Institutional Animal Care and Use Committee guidelines of the University of North 
Carolina at Chapel Hill.
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One-way mixed lymphocyte reaction (MLR) was performed using splenocytes from wild 
type controls and ONZIN deficient mice as described previously22. Briefly, single-cell 
suspensions of responder splenocytes (collected from C57BL/6mice) were reconstituted at 
various concentrations and were mixed with irradiated stimulator splenocytes (isolated from 
BALB/c mice) at the indicated ratios. Cells in suspension were pelleted at 1300 rpm for 5 
minutes at 4° C and resuspended in 5 ml of RBC lysis buffer (0.144 M NH4Cl, 1 mM 
KHCO3 in dH20). RBCs were lysed for 10 minutes at 4° C and the remaining cells were 
washed twice with PBS. Splenocytes were then resuspended in RPMI 1640 medium 
supplemented with 10% FCS, 50 μM BME, 0.08 U/ml penicillin, 0.04 mg/ml gentamicin, 2 
mM L-glutamine, and 10 mM HEPES. Stimulator cells were irradiated at 2400 rads. 
Responder cells (90 μl at various concentrations) were mixed with irradiated stimulator 
splenocytes (4 × 105) in a total of 180 μl. Cells were cultured in a 5% CO2 humidified 
incubator at 37°C for 48 hours. After 48 hours of incubation, cells were pulsed with 20 μl of 
0.5 μCi 3H-thymidine per well for the final 18 hours of culture. The cells were harvested 
onto a glass fiber filtermat, and the amount of 3H-thymidine incorporated in cells was 
assessed by Betaplate scintillation counting. Values are expressed as specific counts per 
minute, which are calculated from counts in wells with responders alone subtracted from 
counts in wells with responders and stimulators. Within each experiment, individual 
conditions were examined in quadruplicate samples.
Spenocytes for the mixed lymphocyte reaction were isolated as follows: cells isolated from 
spleen were pelleted at 1300 rpm for 5 minutes at 4° C and resuspended in 5 ml of RBC 
lysis buffer (0.144 M NH4Cl, 1 mM KHCO3 in dH20). RBCs were lysed for 10 minutes at 
4° C and the remaining cells were washed twice with PBS. Splenocytes were then 
resuspended in RPMI 1640 medium supplemented with 10% FCS, 50 μM BME, 0.08 U/ml 
penicillin, 0.04 mg/ml gentamicin, 2 mM L-glutamine, and 10 mM HEPES and used for the 
MLR.
Contact hypersensitivity to Oxazalone
Wild type and Onzin−/− C57BL/6 mice were anesthetized with 2,2,2-tribromoethanol and 
the plane of anesthesis determined by pinching the mouse toe. Mice were sensitized by 
topical application of 50 μl of 3% oxazalone (4-ethoxymethylene-2-phenyloxazol-5-one; 
Sigma) dissolved in 100% ethanol to all four paw pads as well as the shaved abdomen. After 
5 days, a hypersensitivity reaction was elicited by topical application of 10 μl of 1% 
oxalazone to the left pinna, while the right pinna was unchallenged. At the time points 
examined mice were euthanized, ears collected and an 8-mm diameter disc of tissue was 
obtained from the center of each ear for analysis. The differences in weight between 
experimental (left) and control (right) ears were compared for mice of each genotype. 
Sections of experimental ears were fixed in formalin and stained with Hematoxylin and 
Eosin for analysis. Digital pictures were captured on a Nikon Microphot-FXA microscope at 
4X magnification. Individual fields from each image were analyzed for total cellular content 
in Scion Image program.
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For vascular permeability measurements, sensitized mice were injected 22 hours post 
oxazalone challenge with 1% Evans blue dye (10 ml of dye solution/kg of body weight) that 
was dissolved in PBS and filtered through a 0.2 μm nitrocellulose membrane. Ears were 
harvested after an additional 2 hours, 8 mm discs collected and wet weight determined. Each 
ear disc was incubated in 1 ml formamide at 55° C for 24 hours. Extravasation of Evans blue 
dye was quantified by spectrophotometric analysis of the formamide extracts at 610 nm.
For adoptive transfer response, mice were sensitized with 3% oxazalone as described above. 
On day 5 the axillary and inguinal LNs were collected, cells were flushed from LNs with a 
30-gauge needle with PBS and single cell suspensions prepared. Cells were washed (PBS), 
filtered and 25 × 106 cells were adoptively transferred into recipient mice. Mice were 
immediately challenged with 1% oxazalone. Ear weight was determined 24 hours post 
challenge as described above.
Contact hypersensitivity to DNFB
Onzin+/+ and Onzin−/− 129.B6 F1 hybrids were sensitized with 25 μl of 0.5% DNFB (2,4-
Dinitrofluorobenzene; Sigma) dissolved in acetone:olive oil (4:1) to the hind paws on days 0 
and 1. On day 9, mice were challenged with 0.5% DNFB (10 μl) to the left pinna. Ear 
swelling was measured at the given time points after challenge by analyzing weight 
differences between 8-mm discs obtained from the treated and untreated ears.
Bone Marrow Transplantation
Onzin+/+ and Onzin−/− C57BL/6 mice were lethally irradiated with 1000 rad (Gamma cell; 
GC10 Exactor Cesium-137 irradiator) twice, 3 hours apart. Immediately following the 
second irradiation, mice were reconstituted with bone marrow cells isolated from donor 
mice. Bone marrow was harvested from femurs and tibias of donor mice by flushing with 
PBS (Gibco) and cellular debris was removed by filtering through a miracloth (Calbiochem). 
Cells were resuspended in PBS and each mouse received 2.5 × 107 cells in 0.2 ml through 
the tail vein.
MPO assay
Ear punches (8 mm diameter) were homogenized and analyzed according to a previously 
described protocol23 modified from Bradley et al24. MPO present in the lysed cell 
supernatants was quantified by comparison with a standard curve derived from serial 
dilution of commercial MPO (Calbiochem).
Migration of Langerhan cells
Mice were anesthetized with 2,2,2-tribromoethanol and the plane of anesthesis determined 
by pinching the mouse toe. Onzin+/+ and Onzin−/− C57BL/6 mice were epicutaneously 
sensitized with 50 μl of 0.5% FITC (Sigma Aldrich; in 1:1 acetone:dibutylpthalate) to the 
shaved abdomen. The axillary and inguinal lymph nodes were collected 24 hours after 
sensitization. Cell surface staining of FITC+ CD11c+ (APC-labeled Cd11c, BD Pharmingen) 
Langerhan cells were assayed as described previously25.
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Inflammatory responses induced by Arachidonic Acid
129/SvEv Onzin+/+ and Onzin−/− mice were injected i.v. with 0.5% Evans blue dye as 
describe above. The pinna of the left ear was coated with 20 μl of AA (Sigma; 100 mg/ml in 
acetone) to induce an inflammatory response, while the right ear received vehicle. After 1 hr 
mice were euthanized, and an 8-mm-diameter disc of tissue was obtained from the center of 
each ear for analysis. The wet weight of each ear biopsy was determined to assess edema 
formation. Each ear disc was then incubated in 1 ml formamide at 55° C for24 hours and 
extravasation of Evans blue dye was quantified as described above. Data are expressed as 
mean differences between experimental and control ears for each animal.
Western analysis
Wild type and ONZIN deficient mice were sensitized and challenged with Oxazalone as 
described above. Either 24 or 48 hours after challenge, Evans blue dye was injected into the 
ear in order to locate the draining auricular lymph nodes associated with each ear. Auricular 
lymph nodes were collected and lysates prepared from naïve mice, those associated with the 
treated ear as well as those associated with the untreated ear. The ONZIN specific antibody 
was produced as described previously1.
Isolation of RNA and proteins from ears of challenged mice
Frozen ears were homogenized mechanically by pounding into powder on dry ice. RNA was 
extracted from tissue using RNA isolation solvent (RNA-Bee, Tel-Test. Inc) according to 
manufacturer protocol. RNA (5–10 μg) was reverse transcribed and cDNA was amplified 
with Taqman PCR Universal Master Mix (Applied Biosystems) using the Applied 
Biosystems 7900 HT Fast RT-PCR System. All samples were run in duplicate or triplicate 
and relative expression was determined by normalizing samples to either GAPDH or HPRT 
housekeeping genes. Protein was extracted from tissue in phosphate buffer saline (PBS) 
containing protease inhibitors [2 mM phenylmethylsulfonyl fluoride and Complete Mini 
protease inhibitor cocktail tablet (Roche)] for 20 min at 4° C follow by sonication for 10s. 
Homogenized samples were centrifuged for 20 min at 15,000 g and 4° C. Supernatant was 
analyzed for CXCL1, IL-6 and IL-12 by ELISA (Duo set, R&D system).
Flow cytometry
Draining auricular lymph nodes were collected from challenged mice and the cellular 
composition was analyzed by flow cytometry (FACSCalibur, Becton Dickinson). Antibodies 
from BD Pharmingen: APC-labeled GR-1 for neutrophils; PE-labeled Mac-1 for 
macrophages; APC-labeled CD11c for dendritic cells; PE-labeled B220 for B cells; and 
APC-labeled CD3, FITC-labeled CD4, PE-labeled CD8 for T cells. FITC labeled GR-1, PE-
labeled Mac-1 and PE-labeled MHCII (Miltenyi Biotec) were used for analysis of 
expression of various markers of DC maturation/activation.
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Figure 1. ONZIN expression in draining auricular lymph nodes after challenge with Oxazalone
A, Either 24 or 48 hours after Oxazalone challenge, Evans blue dye was injected into the ear 
of C57Bl/6 mice. The auricular lymph nodes, visualized by the blue dye, associated with the 
treated ear (+) or the untreated ear (−) were collected and protein lysate prepared. Naive 
Onzin+/+ (WT) and Onzin−/− (KO) lymph nodes were collected from mice of the same 
genetic background. Protein lysates were prepared and analyzed by SDS-western and 
visualized with an ONZIN specific antibody. 10 μg total protein was loaded for each sample 
and β-actin was used as a loading control. B, The relative level of ONZIN expression as 
shown by western analysis was quantified using Scion Image software and was adjusted 
relative to the loading control, β-actin. N=4,4 and *p<.05, **p<.01.
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Figure 2. Delayed-type hypersensitivity response in Onzin−/− mice in response to Oxazalone
A, Increase of ear swelling in Onzin+/+ and Onzin−/− C57Bl/6 mice from Oxazalone 
induced DTH response at different timepoints after challenge. n=5,5 at 6 hrs; n=6,6 at 12 
hrs; n=15,15 at 24 hrs; n=30,29 at 48 hrs. *p, **p<.001. B, Histology of ear tissue 24 hrs 
after challenge with Oxazalone or vehicle was visualized by Hematoxylin-eosin staining at 
4x magnification. C, Total-infiltrating cells per field were enumerated from a blinded set of 
histology sections of oxazalone and vehicle challenged ears using Scion Image. N=8,10 and 
*p<.001. D, Lysates were prepared of Oxazalone (O) or vehicle (V) challenged ear skin 
harvested 24 hrs post challenge. MPO concentrations were measured from the ear lysates. 
N=5,6 for vehicle and Oxazalone and is representative of two independent experiments. 
*p<.05. E, Vascular permeability in response to Oxazalone was measured by injecting 
Evans blue dye i.v. into Oxazalone sensitized/challenged mice 2 hrs prior to the 24 hr 
harvest time point. Exudative dye in the ear skin was extracted for 24 hrs and the absorbance 
at 610 nm was determined. N=5,5 and is representative of two independent experiments. 
*p<.01. F, Onzin+/+ and Onzin−/− mice received 0.5% Evans blue dye i.v. immediately 
prior to application of AA (2 mg in acetone) to the left ear. The right ear received acetone 
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alone. After 1 hr, ears were collected and discs were cut for analysis. The wet weight 
difference between the treated and untreated ears of each animal was calculated as an 
indicator of tissue edema. G, Extravasation of plasma proteins into tissue was quantified by 
extraction of dye with formamide and spectrophotometric analysis of extracts at 610 nm. 
The difference between the A610 for the left and right ears of each mouse is indicated. n=5,5.
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Figure 3. Impaired delayed-type hypersensitivity response in Onzin−/− mice to DNFB challenge
Increase of ear swelling in Onzin+/+ and Onzin−/− 129.B6 F1 hybrid mice from DNFB 
induced DTH response 24 and 48 hours after the second challenge. N=5,5 at 24 hrs and 
n=13,15 at 48 hrs. **p<.01.
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Figure 4. Cellular involvement in DTH response
A, Wild type and Onzin−/− mice were lethally irradiated and reconstituted with either 2.5 x 
107 BMCs from Onzin+/+ or Onzin−/− mice. Mice were allowed to recover for 4 weeks and 
then were sensitized and challenged with Oxazalone as described previously. n=21,22,21,19 
and is combination of three independent experiments. *p<.01 (WT:WT versus KO:WT), 
**p<.05 (WT:KO versus KO:KO), #p<0.001 (WT:WT versus KO:KO). B, WT mice were 
depleted of PMNs by injections with the RB6.8C5 antibody prior to sensitization and 
challenge with oxazalone. Ear tissue was harvested and changes in ear weight were 
measured in comparison with vehicle treated ears from the same mouse. C, The absence of 
PMNs was verified in the oxazalone challenged ear tissue from mice receiving the RB6.8C5 
antibody versus those receiving no antibody treatment by assessment of MPO in the ear 
lysates. D, The ability of epithelial cells to acquire antigen and migrate to draining lymph 
nodes was determined by FACs analysis. Onzin+/+ and Onzin−/− mice were epicutaneously 
sensitized with 0.5% FITC and 24 hrs later axillary and inguinal lymph nodes were 
harvested, cells collected and incubated with CD11c antibody. The percentages of FITC+ 
CD11c+ cells contained within the total sensitized LN cell population are shown in D. E, 
The percentage of CD11c+ gated cells (versus isotype control) that are also positive for 
FITC expression (versus unstained cells) from the inguinal LN. n=5,5. F, Differing numbers 
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of responder cells, as indicated on the X-axis, were co-cultured with 4 × 105 irradiated 
stimulator cells. Proliferation of the responder cells was determined by addition of 3H 18 hrs 
prior to harvest of the cells. Suspensions of responder splenocytes were harvested from 
Onzin+/+ and Onzin−/− C57Bl/6 mice and irradiated stimulator splenocytes were collected 
from Onzin+/+ BALB/c mice. N=5,5. G, Suspensions of responder splenocytes were 
obtained from Onzin+/+ and Onzin−/− C57Bl/6 mice and irradiated stimulator splenocytes 
were collected from Onzin−/−BALB/c mice. N=5,5.
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Figure 5. Response to Oxazalone in wild type and Onzin−/− mice after sensitized cellular 
transplants
A, Cells were flushed from oxazalone sensitized LNs, enumerated, and populations analyzed 
by flow cytometry. The percentage of each type, as obtained by flow cytometry, was 
multiplied by the total number of cells contained in each LN to determine the total cells of 
each type present in the LN. B, Populations of CD4+ and CD8+ T cells that were adoptively 
transferred were determined by cell surface antibody staining and flow cytometry analysis 
and were equivalent between WT and Onzin−/− mice. C, Wild type and Onzin−/− mice were 
sensitized with Oxazalone. Five days later, draining lymph nodes were harvested and 2.5 × 
107 cells were adoptively transferred into wild type of Onzin−/− recipient mice. Mice were 
then immediately challenged with Oxazalone and ear swelling measured 24 hrs later. 
N=4,11,9 and is combination of two independent experiments. **p<.01. D, 24 hr after 
oxazolone challenge, Evans blue dye was injected to ear and auricular lymph nodes identify 
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by blue color were isolated. Cells from lymph node were isolated and analyzed by cell 
surface staining and FACS. (n=9,9). E, Analysis of CD11c+ dendritic cells from the 
draining nodes for expression of Mac-1, MHCII and GR-1. (n=6,6)
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Figure 6. Expression of cytokines in mouse ears after challenge with oxazolone
Wild type and Onzin−/− mice were sensitized and challenged with 1% oxazolone or vehicle. 
Vehicle and oxazalone treated ears were harvested either 6 or 16 hrs post challenge and 
RNA or proteins were isolated for analysis. Quantitative analysis of A, IL-6 and B, CXCL1 
RNA expression by RT-PCR. Quantitative analysis of protein for presence of C, IL-6 and D, 
CXCL1 as measured by ELISA. n=5, *p< 0.05. Quantitative analysis of IL-2 (E), IL-4 (F), 
IL-17e (G), CCR6 (H), CCR7 (I) by RT-PCR 6 hrs post challenge and IL-12 (J) by ELISA 
16 hrs post challenge.
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